In a functional-clinical study of SCN2A variants, Berecki et al. provide new insights into the molecular mechanism of Nav1.2 channel inactivation, predict the impact of non-inactivating Nav1.2 variants on neuronal function and inform treatment strategies for SCN2A-related developmental and epileptic encephalopathy. Here, SCN2A is linked to developmental and epileptic encephalopathy.